Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af7394d3a5bf9284d134a4863b5ea31d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa914607a48c5308b1956401e1635451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4d85dc0ca838009f53f70626c4c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3ad71c5636688758e6d20dda3ea6aca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 |
filingDate |
2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca95372842d567befdaff97025416a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb620c50ab0ae3d21ee12b5a1a669ce6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d6b1ca0713861179d3494a138089581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6216fd3e0af6ca49cc19cf18bd823560 |
publicationDate |
2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012015423-A1 |
titleOfInvention |
Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
abstract |
The invention relates to novel insertion sites useful for the integration of HIV DNA sequences into the MVA genome, and to the resulting recombinant MVA derivatives. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8197822-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309098-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8288125-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309326-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8198088-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016030551-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707291-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012178157-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323661-B2 |
priorityDate |
2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |